Search results
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 6 hours agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 1 day agoThe CDC has recommended that adults 65 and older and people who are immunocompromised get a booster...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 2 days agoIdeally, these updated vaccines will be available in the fall. The Vaccines and Related Biological...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 4 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
FDA approves Moderna’s mRNA RSV vaccine
The Hill via Yahoo News· 6 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 4 days agoSo, even if Moderna shares don't take off overnight, the RSV approval is bullish news for shareholders -- and a great reason...provides investors with an...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 2 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
InvestorPlace· 8 hours agoVaccine maker Novavax (NASDAQ:NVAX) saw its shares jump 18% on June 5 and another 20% in pre-market...
FDA advisers urge targeting JN.1 strain for fall’s COVID vaccines
Marshall Independent· 15 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of ...
FDA advisers: Next COVID shots should target variants with JN.1 lineage | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 1 day agoAdvisers to the U.S. Food and Drug Administration today unanimously voted in favor of recommending...